These are basically smokescreens that companies can hide behind so they dont have to reveal the exact amounts of ingredients that are in their products
And imagine if you start to understand how to really utilize these peptides where, use it in the morning, use it at night, and use it in the middle of the day
While NO is largely implicated in hemostatic mechanisms, in tail-amputation-models under heparin- and warfarin-administration, both the NO-synthase (NOS)-blocker, L-NAME (prothrombotic) and the NOS-substrate L-arginine (antithrombotic), were little investigated
These processes involve the activation of muscarinic cholinergic receptors in the forebrain, and an increased expression of type-2 metabotropic glutamate (mGlu2) receptors in dorsal root ganglia neurons
My diabetic patients typically have significant ocular surface disease, so Im hopeful that managing diabetes with GLP-1 therapy will promote improvement
So, it can only be from exogenous sources